Columbus, OHNCT07062588Now EnrollingIRB Ready

Osteogenesis Imperfecta (OI) Clinical Trial in Columbus, OH

Access cutting-edge osteogenesis imperfecta (oi) treatment through this clinical trial at a research site in Columbus. Study-provided care at no cost to qualified participants.

Sponsored by Angitia Incorporated Limited

Quick Self-Assessment

See if you qualify for this Columbus location

Preparing your pre-screening questions…

Expert Care in Columbus

Access osteogenesis imperfecta (oi) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related osteogenesis imperfecta (oi) treatment provided free

Apply for This Columbus Location

Check if you qualify for this osteogenesis imperfecta (oi) clinical trial in Columbus, OH

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Columbus

    Convenient for OH residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Columbus site if eligible
  4. 4Begin participation

About This Osteogenesis Imperfecta (OI) Study in Columbus

This study will determine the effect of treatment of AGA2115 in adults with Type I, III, or IV osteogenesis imperfecta versus placebo.

Sponsor: Angitia Incorporated Limited

Who Can Participate

Inclusion Criteria

Male or female adults (aged 18 to 75 years inclusive) with a clinical diagnosis of osteogenesis imperfecta Type I, III, or IV with documented genetic testing confirmation of genetic variations in the COL1A1 or COL1A2 genes
Capable of giving signed informed consent which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in the protocol
BMD T-score of ≤ -1.0 at the lumbar spine, total hip, or femoral neck

Exclusion Criteria

Vitamin D deficiency
Concomitant uncontrolled diseases or conditions that could affect bone metabolism such as hypo-/hyperparathyroidism, hypo-/hyperthyroidism, abnormal thyroid function or thyroid disease, or other endocrine disorders
Current hyper- or hypocalcemia
History of rickets or osteomalacia or any skeletal condition (other than OI) leading to long-bone deformities and/or increased risk of fractures
Treatment with bisphosphonates within the past 6 months
Treatment with teriparatide, abaloparatide, strontium ranelate, or hormone replacement therapy within the past 12 months
Treatment with denosumab (or denosumab biosimilars) within the past 2 years
Treatment with anti-sclerostin antibody medications (romosozumab, setrusumab, blosozumab) at any time
History of myocardial infarction or stroke (or other cardiovascular associated event deemed significant) within the past 12 months
Malignancy within the last 5 years
Pregnant or breastfeeding women, or women planning to become pregnant during the study
Participation in any clinical study within the past 12 months during which the participant was administered any IP (participant must also agree not to enroll in any other clinical study concurrently in which IP is administered)

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Columbus?

Yes, this clinical trial (NCT07062588) has an active research site in Columbus, OH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Osteogenesis Imperfecta (OI) Treatment Options in Columbus, OH

If you're searching for osteogenesis imperfecta (oi) treatment options in Columbus, OH, this clinical trial (NCT07062588) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Columbus research site is actively enrolling participants for this clinical trial. You'll receive care from experienced osteogenesis imperfecta (oi) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all osteogenesis imperfecta (oi) clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Columbus, OH

See all pulmonary embolism clinical trials recruiting in Columbus — not just this study.

Browse Pulmonary Embolism Trials in Columbus →

Browse More Trials by Condition

Pulmonary Embolism TrialsOsteogenesis Imperfecta TrialsAll Conditions →

Ready to Join in Columbus?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Columbus, OH